fesoterodine fumarate
fesoterodine fumarate is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including fesoterodine fumarate, Toviaz. Available dosage form: tablet, film coated, extended release.
Drug details
- Generic Name
- fesoterodine fumarate
- Brand Names
- fesoterodine fumarate, Toviaz
- Application Number
- ANDA204946
- Sponsor
- Zydus Pharmaceuticals USA Inc.
- NDC Codes
- 6
- Dosage Forms
- TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- FESOTERODINE FUMARATE
Indications and Usage
1 INDICATIONS AND USAGE Fesoterodine fumarate extended-release tablets are indicated for the treatment of: Overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. ( 1.1 ) 1.1 Adult Overactive Bladder Fesoterodine fumarate extended-release tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Pediatric use information is approved for Pfizer Inc.'s TOVIAZ ® (fesoterodine fumarate) Extended-Release Tablets. However, due to Pfizer Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information.